Skip to main content
. 2024 Feb 15;11(1):e001114. doi: 10.1136/lupus-2023-001114

Table 3.

Definitions for DORIS-remission and LLDAS

Features DORIS-remission LLDAS
Main purpose Defines a state of remission in SLE Represents a state of low disease activity in SLE
Disease Activity Score Clinical SLEDAI=0 SLEDAI-2K ≤4 with no activity in major organ systems (renal, CNS, cardiopulmonary, vasculitis, fever), and no haemolytic anaemia or gastrointestinal activity
No new lupus disease activity compared with the previous assessment
Physician Global Assessment <0.5 (0–3) ≤1 (0–3)
Glucocorticoids Prednisolone ≤5 mg/day or equivalent Prednisolone ≤7.5 mg/day or equivalent
Other treatments Stable antimalarials, immunosuppressives and biologics Well-tolerated standard maintenance doses of immunosuppressive drugs and approved biological agents

CNS, central nervous system; DORIS, Definitions Of Remission In SLE; LLDAS, Lupus Low Disease Activity State; SLEDAI-2K, SLE Disease Activity Index 2000.